Form EFFECT Astria Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 27, 2026 |
| Accession Number: | 0001140361-26-002208 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EATALY DEBUTS FIRST-EVER BRAND FILM WITH SOCCER LEGEND ALESSANDRO DEL PIERO IN ITS LARGEST CAMPAIGN TO DATE
- Cover Whale Insurance Launches Breakwater Markets and Appoints Roman Atkielski to Lead Brokerage Offering
- Phenom Recognized Among the Four Highest Scoring Vendors Across Every Use Case in the Gartner Critical Capabilities for Talent Acquisition (Recruiting) Suites
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share